Trial Profile
A Randomized, Double-blind, Active-controlled, Single-center, Phase 1 Study to Determine the Pharmacodynamic and Safety of MBA-P01 in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Jan 2020
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Blepharospasm; Equinus foot deformity; Glabellar lines; Hypertrophy; Muscle spasticity; Overactive bladder; Spasm; Torticollis
- Focus Pharmacodynamics
- Sponsors Medytox
- 25 Mar 2019 Status changed from recruiting to completed.
- 11 Jun 2018 New trial record